{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T11:42:17Z","timestamp":1780054937092,"version":"3.54.0"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,12]],"date-time":"2024-11-12T00:00:00Z","timestamp":1731369600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.vaccine.2024.126508","type":"journal-article","created":{"date-parts":[[2024,11,15]],"date-time":"2024-11-15T15:29:23Z","timestamp":1731684563000},"page":"126508","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"P2","title":["Development and validation of a standardized human complement serum bactericidal activity assay to measure functional antibody responses to Neisseria gonorrhoeae"],"prefix":"10.1016","volume":"43","author":[{"given":"Kathryn A.","family":"Matthias","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Reveille","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kumaresh","family":"Dhara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher S.","family":"Lyle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert J.","family":"Natuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Bonk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret C.","family":"Bash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2024.126508_bb0005","doi-asserted-by":"crossref","first-page":"219","DOI":"10.3390\/vaccines8020219","article-title":"The Neisseria gonorrhoeae vaccine candidate NHBA elicits antibodies that are bactericidal, opsonophagocytic and that reduce gonococcal adherence to epithelial cells","volume":"8","author":"Semchenko","year":"2020","journal-title":"Vaccines"},{"key":"10.1016\/j.vaccine.2024.126508_bb0010","article-title":"Characterization of protective immune responses against Neisseria gonorrhoeae induced by intranasal immunization with adhesion and penetration protein","volume":"10","author":"Xia","year":"2024","journal-title":"Heliyon"},{"key":"10.1016\/j.vaccine.2024.126508_bb0015","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0162878","article-title":"Neisserial heparin binding antigen (NHBA) contributes to the adhesion of Neisseria meningitidis to human epithelial cells","volume":"11","author":"Vacca","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2024.126508_bb0020","doi-asserted-by":"crossref","first-page":"e02519","DOI":"10.1128\/mBio.02552-19","article-title":"Preclinical efficacy of a lipooligosaccharide peptide mimic candidate gonococcal vaccine","volume":"10","author":"Gulati","year":"2019","journal-title":"mBio"},{"key":"10.1016\/j.vaccine.2024.126508_bb0025","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1093\/infdis\/jiy609","article-title":"A meningococcal native outer membrane vesicle vaccine with attenuated endotoxin and overexpressed factor H binding protein elicits gonococcal bactericidal antibodies","volume":"219","author":"Beernink","year":"2019","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2024.126508_bb0030","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1093\/infdis\/jiab450","article-title":"Meningococcal detoxified outer membrane vesicle vaccines enhance gonococcal clearance in a murine infection model","volume":"225","author":"Matthias","year":"2022","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2024.126508_bb0035","first-page":"e00309","article-title":"Evaluating vaccine-elicited antibody activities against Neisseria gonorrhoeae: cross-protective responses elicited by the 4CMenB meningococcal vaccine","volume":"91","author":"Gray","year":"2023","journal-title":"Vaccines"},{"key":"10.1016\/j.vaccine.2024.126508_bb0040","series-title":"Neisseria gonorrhoeae","first-page":"267","article-title":"Complement-dependent serum bactericidal assays for Neisseria gonorrhoeae","author":"Gulati","year":"2019"},{"key":"10.1016\/j.vaccine.2024.126508_bb0045","first-page":"7","article-title":"Feasibility of using a luminescence-based method to determine serum bactericidal activity against Neisseria gonorrhoeae","author":"Clow","year":"2019","journal-title":"Vaccines"},{"key":"10.1016\/j.vaccine.2024.126508_bb0050","article-title":"High-throughput bactericidal assays for monoclonal antibody screening against antimicrobial resistant Neisseria gonorrhoeae","volume":"16","author":"Stazzoni","year":"2023","journal-title":"Front Microbiol"},{"key":"10.1016\/j.vaccine.2024.126508_bb0055","doi-asserted-by":"crossref","first-page":"3374","DOI":"10.1128\/iai.64.8.3374-3378.1996","article-title":"Functional characterization of a Sialyltransferase-deficient mutant of Neisseria gonorrhoeae","volume":"64","author":"Gill","year":"1996","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2024.126508_bb0060","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/S0161-5890(99)00114-5","article-title":"The contrasting mechanisms of serum resistance of Neisseria gonorrhoeae and group B Neisseria meningitidis","volume":"36","author":"Ram","year":"1999","journal-title":"Mol Immunol"},{"key":"10.1016\/j.vaccine.2024.126508_bb0065","series-title":"The complement system","first-page":"23","article-title":"Method for depletion of IgG and IgM from human serum as naive complement source","author":"Zwarthoff","year":"2021"},{"key":"10.1016\/j.vaccine.2024.126508_bb0070","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1128\/jb.85.6.1274-1279.1963","article-title":"I. Virulence genetically linked to clonal variation","volume":"85","author":"Kellogg","year":"1963","journal-title":"J Bacteriol"},{"key":"10.1016\/j.vaccine.2024.126508_bb0075","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1128\/iai.54.1.63-69.1986","article-title":"Antigenic and physical diversity of Neisseria gonorrhoeae lipooligosaccharides","volume":"54","author":"Mandrell","year":"1986","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2024.126508_bb0080","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1128\/iai.40.1.257-264.1983","article-title":"Importance of complement source in bactericidal activity of human antibody and murine monoclonal antibody to meningococcal group B polysaccharide","volume":"40","author":"Zollinger","year":"1983","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2024.126508_bb0085","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1084\/jem.168.2.507","article-title":"Purification and characterization of eight class 5 outer membrane protein variants from a clone of Neisseria meningitidis serogroup a","volume":"168","author":"Achtman","year":"1988","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2024.126508_bb0090","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1111\/mmi.13747","article-title":"Heterogeneity in non-epitope loop sequence and outer membrane protein complexes alters antibody binding to the major porin protein PorB in serogroup B Neisseria meningitidis","volume":"105","author":"Matthias","year":"2017","journal-title":"Mol Microbiol"},{"key":"10.1016\/j.vaccine.2024.126508_bb0095","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1128\/CVI.00812-13","article-title":"Development and use of a serum bactericidal assay using pooled human complement to assess responses to a meningococcal group a conjugate vaccine in African toddlers","volume":"21","author":"Bash","year":"2014","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2024.126508_bb0100","first-page":"970","article-title":"Interlaboratory standardization of the measurement of serum bactericidal activity by using complement against meningococcal serogroup B, strain 44\/76-SL, before and after vaccination with the Norwegian MenBvac outer membrane vesicle vaccine","volume":"12","author":"Borrow","year":"2005","journal-title":"Clin Diagn Lab Immunol"},{"key":"10.1016\/j.vaccine.2024.126508_bb0105","first-page":"2","article-title":"Lipooligosaccharide structure is an important determinant of the resistance of Neisseria gonorrhoeae to antimicrobial agents of innate host defense","author":"Balthazar","year":"2011","journal-title":"Front Microbiol"},{"key":"10.1016\/j.vaccine.2024.126508_bb0110","doi-asserted-by":"crossref","first-page":"4094","DOI":"10.1128\/IAI.00433-06","article-title":"\u03b1-2,3,-Sialyltransferase enhances Neisseria gonorrhoeae survival during experimental murine genital tract infection","volume":"74","author":"Wu","year":"2006","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2024.126508_bb0115","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/j.1574-6968.2007.00776.x","article-title":"A fully defined, clear and protein-free liquid medium permitting dense growth of Neisseria gonorrhoeae from very low inocula","volume":"273","author":"Wade","year":"2007","journal-title":"FEMS Microbiol Lett"},{"key":"10.1016\/j.vaccine.2024.126508_bb0120","doi-asserted-by":"crossref","first-page":"298","DOI":"10.4049\/jimmunol.147.1.298","article-title":"Lysis of Neisseria gonorrhoeae initiated by binding of normal human IgM to a hexosamine-containing lipooligosaccharide epitope(s) is augmented by strain-specific, properdin-binding-dependent alternative complement pathway activation","volume":"147","author":"Griffiss","year":"1991","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2024.126508_bb0125","doi-asserted-by":"crossref","first-page":"2617","DOI":"10.1111\/j.1365-2958.1992.tb01439.x","article-title":"Antibodies to N-terminal peptides of gonococcal Porin are bactericidal when gonococcal lipopolysaccharide is not Sialylated","volume":"6","author":"Elkins","year":"1992","journal-title":"Mol Microbiol"},{"key":"10.1016\/j.vaccine.2024.126508_bb0130","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1128\/iai.60.1.39-43.1992","article-title":"Gonococcal Lipooligosaccharide sialylation prevents complement-dependent killing by Immne sera","volume":"60","author":"Wetzler","year":"1992","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2024.126508_bb0135","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1084\/jem.188.4.671","article-title":"Binding of complement factor H to loop 5 of porin protein 1A: a molecular mechanism of serum resistance of nonsialylated Neisseria gonorrhoeae","volume":"188","author":"Ram","year":"1998","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2024.126508_bb0140","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1084\/jem.187.5.743","article-title":"A novel sialic acid binding site on factor H mediates serum resistance of sialylated Neisseria gonorrhoeae","volume":"187","author":"Ram","year":"1998","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2024.126508_bb0145","doi-asserted-by":"crossref","first-page":"4489","DOI":"10.4049\/jimmunol.178.7.4489","article-title":"Factor H binding and function in sialylated pathogenic neisseriae is influenced by gonococcal, but not meningococcal, porin","volume":"178","author":"Madico","year":"2007","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2024.126508_bb0150","doi-asserted-by":"crossref","first-page":"3894","DOI":"10.1128\/IAI.68.7.3894-3899.2000","article-title":"The lipopolysaccharide structures of salmonella enterica serovar typhimurium and Neisseria gonorrhoeae determine the attachment of human mannose-binding lectin to intact organisms","volume":"68","author":"Devyatyarova-Johnson","year":"2000","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2024.126508_bb0155","doi-asserted-by":"crossref","first-page":"4078","DOI":"10.4049\/jimmunol.168.8.4078","article-title":"Regulation of the Mannan-binding lectin pathway of complement on Neisseria gonorrhoeae by C1-inhibitor and \u03b12-macroglobulin","volume":"168","author":"Gulati","year":"2002","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2024.126508_bb0160","doi-asserted-by":"crossref","DOI":"10.1093\/femspd\/ftx049","article-title":"Gonococcal lipooligosaccharide sialylation: virulence factor and target for novel immunotherapeutics","volume":"75","author":"Ram","year":"2017","journal-title":"Pathog Dis"},{"key":"10.1016\/j.vaccine.2024.126508_bb0165","doi-asserted-by":"crossref","first-page":"321","DOI":"10.3389\/fimmu.2019.00321","article-title":"Targeting Lipooligosaccharide (LOS) for a Gonococcal Vaccine","volume":"10","author":"Gulati","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.vaccine.2024.126508_bb0170","first-page":"3295","article-title":"Cytidine 5\u2032-monophospho-N-acetylneuraminic acid or a related compound is the low Mr factor from human red blood cells which induces gonococcal resistance to killing by human serum","volume":"134","author":"Nairn","year":"1988","journal-title":"J Gen Microbiol"},{"key":"10.1016\/j.vaccine.2024.126508_bb0175","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1128\/cdli.4.2.156-167.1997","article-title":"Standardization and a multilaboratory comparison of Neisseria meningitidis serogroup a and C serum bactericidal assays","volume":"4","author":"Maslanka","year":"1997","journal-title":"Clin Diagn Lab Immunol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X24011903?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X24011903?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,18]],"date-time":"2024-12-18T03:21:13Z","timestamp":1734492073000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X24011903"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":35,"alternative-id":["S0264410X24011903"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2024.126508","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development and validation of a standardized human complement serum bactericidal activity assay to measure functional antibody responses to Neisseria gonorrhoeae","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2024.126508","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"126508"}}